Hani Sayed Hafez
Hani Sayed Hafez publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry, on topics such as Synthesis and biological activity, Metal complexes synthesis and properties and Chemotherapy-induced organ toxicity mitigation.
- World rank
- #3,313,147 of 7,710,434 ranked researchers
- Rank in Egypt
- #10,581 of 36,277
- Works
- 54
- Citations
- 824
- Citations per work
- 15.3
What does Hani Sayed Hafez research?
Hani Sayed Hafez's work is mostly in Medicine (26%), Biochemistry, Genetics and Molecular Biology (15%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2851.8%
- Health Sciences1425.9%
- Medicine1425.9%
- Life Sciences815.1%
- Physical Sciences47.2%
- Chemistry47.2%
- 1Molecular Biology15% of their works
- 2Pulmonary and Respiratory Medicine9% of their works
- 3Organic Chemistry7% of their works
- 4Oncology6% of their works
- 5Physiology6% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Synthesis and biological activity
- Metal complexes synthesis and properties
- Chemotherapy-induced organ toxicity mitigation
- Fibroblast Growth Factor Research
- Neonatal Respiratory Health Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Retinoids in leukemia and cellular processes
- Cancer therapeutics and mechanisms
Which keywords describe Hani Sayed Hafez's research?
The keywords of their largest research topics: Anticancer Agents, Chemotherapy, Cisplatin, Cisplatin Resistance, Heterocyclic Compounds, Medicinal Chemistry, Nephrotoxicity and Platinum-Based Drugs.
- Topoisomerases
- DNA
- Preterm Infants
- Fibrosis
- FGF21
- Platinum-Based Drugs
- Medicinal Chemistry
- Cisplatin Resistance
- Chemotherapy
- Anticancer Agents
- Cisplatin
- Heterocyclic Compounds
- Nephrotoxicity
- Bronchopulmonary Dysplasia
- Fibroblast Growth Factor
- Idiopathic Pulmonary Fibrosis
- Acute Promyelocytic Leukemia
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Anticancer Agents102 topics
- Chemotherapy82 topics
- Cisplatin51 topic
- Cisplatin Resistance51 topic
- Heterocyclic Compounds51 topic
- Medicinal Chemistry51 topic
- Nephrotoxicity51 topic
- Platinum-Based Drugs51 topic
- Bronchopulmonary Dysplasia41 topic
- FGF2141 topic
- Fibroblast Growth Factor41 topic
- Fibrosis41 topic
- Idiopathic Pulmonary Fibrosis41 topic
- Preterm Infants41 topic
- Acute Promyelocytic Leukemia31 topic
- DNA31 topic
- Retinoic Acid31 topic
- Topoisomerases31 topic
Where does Hani Sayed Hafez work?
Hani Sayed Hafez's main affiliation in the publication record is Suez University, Egypt.
How many publications and citations does Hani Sayed Hafez have?
OpenAlex counts 54 works and 824 citations for Hani Sayed Hafez, an h-index of 13, ranking #3,313,147 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hani Sayed Hafez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.